Ceretype Neuromedicine, Inc. — Form D
Ceretype Neuromedicine, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-18. The offering totals $400K, of which $400K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-12-18
- Form: D
- Accession: 0001884863-25-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $400K
- Amount sold: $400K
- Investors: 3
- Date of first sale: 2024-08-06
- Revenue range: Decline to Disclose
- SEC file number: 021-567252
Issuer
- Name: Ceretype Neuromedicine, Inc.
- CIK: 0001884863
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1 Broadway, 14th Floor, Cambridge, MA, 02142
- Phone: 917-796-7706
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Richard Lipkin | Director | Cambridge, MA |
| David Silbersweig | Director | Cambridge, MA |
| Emily Stern | Director | Cambridge, MA |
| Emily Stern | Executive Officer | Cambridge, MA |
| Hong Pan | Director | Cambridge, MA |
Other filings by this issuer (1)
More